PURPOSE OF REVIEW: In this review, we update investigations related to cancer biomarkers in HIV-infected populations. RECENT FINDINGS: CD4 lymphocyte count is associated with primary central nervous system lymphoma (PCNSL), systemic non-Hodgkin's lymphoma (NHL) (except perhaps for Burkitt lymphoma), Kaposi's sarcoma, cervical cancer, and anal cancer. HIV load is associated with Burkitt lymphoma and systemic NHL (but not PCNSL), with Kaposi's sarcoma and with anal cancer. CD40 ligand incorporated into the HIV envelope and expression of activation-induced cytidine deaminase may help explain the relationship between HIV load and Burkitt lymphoma. Genetic polymorphisms have been identified that are linked to lymphoma in HIV patients. B-cell activation as manifest in immunoglobulin light chain production may be an important marker for NHL risk. Cytokines and related molecules (IL10, sCD30) may identify patients at high risk for NHL. Epstein-Barr virus (EBV) in cerebrospinal fluid (CSF) is useful as a marker for PCNSL, although with the falling incidence of PCNSL, the specificity of the test has been called into question. EBV and Kaposi's sarcoma-associated herpesvirus (KSHV) have not yet emerged as especially promising markers of risk for either lymphoma or Kaposi's sarcoma. SUMMARY: CD4 lymphocyte count, HIV load, germline genetic polymorphisms, cytokine and related molecules, and immunoglobulin light chains all show increasing promise as biomarkers of malignancy in HIV patients.
PURPOSE OF REVIEW: In this review, we update investigations related to cancer biomarkers in HIV-infected populations. RECENT FINDINGS:CD4 lymphocyte count is associated with primary central nervous system lymphoma (PCNSL), systemic non-Hodgkin's lymphoma (NHL) (except perhaps for Burkitt lymphoma), Kaposi's sarcoma, cervical cancer, and anal cancer. HIV load is associated with Burkitt lymphoma and systemic NHL (but not PCNSL), with Kaposi's sarcoma and with anal cancer. CD40 ligand incorporated into the HIV envelope and expression of activation-induced cytidine deaminase may help explain the relationship between HIV load and Burkitt lymphoma. Genetic polymorphisms have been identified that are linked to lymphoma in HIVpatients. B-cell activation as manifest in immunoglobulin light chain production may be an important marker for NHL risk. Cytokines and related molecules (IL10, sCD30) may identify patients at high risk for NHL. Epstein-Barr virus (EBV) in cerebrospinal fluid (CSF) is useful as a marker for PCNSL, although with the falling incidence of PCNSL, the specificity of the test has been called into question. EBV and Kaposi's sarcoma-associated herpesvirus (KSHV) have not yet emerged as especially promising markers of risk for either lymphoma or Kaposi's sarcoma. SUMMARY:CD4 lymphocyte count, HIV load, germline genetic polymorphisms, cytokine and related molecules, and immunoglobulin light chains all show increasing promise as biomarkers of malignancy in HIVpatients.
Authors: J R Schroeder; A J Saah; D R Hoover; J B Margolick; R F Ambinder; O Martinez-Maza; E C Breen; L P Jacobson; D Variakojis; D T Rowe; H K Armenian Journal: Cancer Epidemiol Biomarkers Prev Date: 1999-11 Impact factor: 4.254
Authors: A E Grulich; X Wan; M G Law; S T Milliken; C R Lewis; R J Garsia; J Gold; R J Finlayson; D A Cooper; J M Kaldor Journal: AIDS Date: 2000-01-28 Impact factor: 4.177
Authors: M Dean; L P Jacobson; G McFarlane; J B Margolick; F J Jenkins; O M Howard; H F Dong; J J Goedert; S Buchbinder; E Gomperts; D Vlahov; J J Oppenheim; S J O'Brien; M Carrington Journal: Cancer Res Date: 1999-08-01 Impact factor: 12.701
Authors: Elizabeth Crabb Breen; Sepi Fatahi; Marta Epeldegui; W John Boscardin; Roger Detels; Otoniel Martínez-Maza Journal: Tumour Biol Date: 2006-04-27
Authors: Elizabeth Crabb Breen; W John Boscardin; Roger Detels; Lisa P Jacobson; Michael W Smith; Stephen J O'Brien; Joan S Chmiel; Charles R Rinaldo; Shenghan Lai; Otoniel Martínez-Maza Journal: Clin Immunol Date: 2003-11 Impact factor: 3.969
Authors: Charles S Rabkin; Eric A Engels; Ola Landgren; Rob Schuurman; M Constanza Camargo; James J Goedert Journal: Am J Hematol Date: 2011-10 Impact factor: 10.047
Authors: Marta Epeldegui; Jeannette Y Lee; Anna C Martínez; Daniel P Widney; Larry I Magpantay; Deborah Regidor; Ronald Mitsuyasu; Joseph A Sparano; Richard F Ambinder; Otoniel Martínez-Maza Journal: Clin Cancer Res Date: 2015-09-17 Impact factor: 12.531
Authors: Marta Epeldegui; Larry Magpantay; Yu Guo; Gordana Halec; William G Cumberland; Priscilla K Yen; Bernard Macatangay; Joseph B Margolick; Anne F Rositch; Steven Wolinsky; Otoniel Martinez-Maza; Shehnaz K Hussain Journal: AIDS Date: 2018-04-24 Impact factor: 4.632
Authors: Annalisa Dalzini; Maria Raffaella Petrara; Giovanni Ballin; Marisa Zanchetta; Carlo Giaquinto; Anita De Rossi Journal: J Immunol Res Date: 2020-05-16 Impact factor: 4.818